How can I learn more about azithromycin?

The FDA’s March 2013 notice and an abstract of the NEJM study about azithromycin are available at the following links:

• FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms, U.S. Food and Drug Administration
• Azithromycin and the Risk of Cardiovascular Death, The New England Journal of Medicine

You should also contact The Driscoll Firm, LLC, at our toll-free number or through our online form to speak with an azithromycin heart risk attorney.